Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National Experience.
CONCLUSIONS: SOF-based therapy for patients progressing to liver transplantation leads to high SVR rates, short term stability in liver function, and deactivation from the transplant list.
PMID: 31103148 [PubMed - in process]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Canada Health | Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology | Virology